Skip to main content

Waters Corporation Value Stock - Dividend - Research Selection

Waters corporation

ISIN: US9418481035 , WKN: 898123

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers\' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

2026-06-19
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valued at approximately USD 2.7 Billion in 2025 and is expected to reach USD 2.9 Billion in 2026 and is expected to reach around USD 6.9 Billion by 2035, at a CAGR of 9.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Eppendorf SE, Perki

Waters Corporation Stock: Is WAT Underperforming the Health Care Sector?

2026-06-17
Waters Corporation has lagged behind the broader health care sector over the past year, but analysts remain fairly bullish about its future prospects.

Waters Corp (NYSE:WAT) Technical Setup Signals High-Quality Breakout Opportunity

2026-06-17
Waters Corp (WAT) shows a strong technical breakout setup with a Technical Rating of 7 and Setup Rating of 9, forming a tight consolidation pattern with institutional buying interest and defined support/resistance levels for low-risk entry.

Waters Launches New Tools As Investors Weigh Biologics And Battery Upside

2026-06-12
Waters Corporation (NYSE:WAT) has launched new analytical instrument platforms and workflow solutions, including BioResolve Peptide and GTxResolve Lipid Columns. The company also introduced new high-performance mass spectrometry systems that support biopharmaceutical development, multiomics research, and battery safety testing. These products are aimed at improving characterization of complex biologics and lipids, speeding structural omics analysis, advancing imaging for translational...

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

2026-06-12
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 6.4%, nearly mirroring the S&P 500.

Piper Sandler Initiates Coverage of Waters (WAT) with Neutral Recommendation

2026-06-12

Intel upgraded, Reddit initiated: Wall Street's top analyst calls

2026-06-11
Intel upgraded, Reddit initiated: Wall Street's top analyst calls

Piper Sandler Initiates Coverage On Waters with Neutral Rating, Announces Price Target of $400

2026-06-11
Piper Sandler analyst David Westenberg initiates coverage on Waters (NYSE:WAT) with a Neutral rating and announces Price Target of $400.

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

2026-06-09
Waters Corporation (NYSE: WAT) today announced the launch of the Waters TA Instruments™ Coin Cell Differential Scanning Calorimeter (DSC), designed to transform battery safety testing. Purpose-built for battery scientists, the Coin Cell DSC enables direct testing of fully assembled coin cells, eliminating time-intensive preparation steps while delivering faster, more descriptive safety and performance insights.

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

2026-06-08
55th International Symposium on High Performance Liquid Phase Separations and Related Techniques—Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally and chemically similar impurities in GLP-1 peptides, insulin, and lipid nanoparticles (LNPs) to support the develo